Gastric bypass stent market seen reaching $0.7 billion by 2030

The gastric bypass stent system market is projected to grow from $0.41 billion in 2025 to $0.7 billion by 2030, driven by rising obesity rates, more bariatric surgeries and wider use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The market targets complications tied to bariatric surgery and obesity care, including leaks, strictures and blockages. - Demand is rising for less invasive treatment options that can shorten recovery times and reduce the need for open surgery. - The forecast points to a broader shift toward endoscopic tools, biodegradable materials and robot-assisted procedures in gastrointestinal care.

What happened: - The gastric bypass stent system market is projected to rise from $0.41 billion in 2025 to $0.46 billion in 2026. - The market is forecast to reach $0.7 billion by 2030. - The Business Research Company published the forecast on Sept. 8, 2026. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest through the forecast period. - The company offered a free sample report and a full market report online: Download the sample report and View the full report.

The details: - The 2025-to-2026 growth rate is projected at 11.5% CAGR. - The 2026-to-2030 period is projected to grow at an 11.0% CAGR. - Rising obesity rates, more bariatric surgeries, more gastrointestinal complications after surgery and greater use of hospital-based endoscopic treatments have supported market growth. - Precision medicine in gastrointestinal care is expected to support future demand. - Demand is rising for biodegradable and biocompatible stent materials. - Robotic-assisted endoscopic procedures are becoming more common. - Ambulatory surgical centers are expanding as providers look for faster recovery options. - AI-supported diagnostic tools are increasingly used in gastrointestinal interventions. - Minimally invasive stenting after bariatric surgery is becoming more common. - Self-expanding nitinol stents are gaining use because of their flexibility and lower migration risk. - Fully covered stents are being used more often to manage leaks and support tissue healing. - Advanced biodegradable stents are drawing interest because they reduce the need for device removal. - A gastric bypass stent system is designed to keep a pathway open in the gastrointestinal tract after gastric bypass or related surgeries. - The devices help manage post-surgical complications and provide a minimally invasive alternative to more extensive surgery. - Obesity is defined as a body mass index of 30 or above. - The World Obesity Federation reported in March 2025 that almost 3 billion adults, about half the global adult population, are expected to be overweight or obese by 2030. - Data from the National Library of Medicine in September 2023 showed 7,733 robotic surgical systems installed globally and more than 10 million robotic surgeries performed to date. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 market report adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics, and updated graphics and tables.

Between the lines: - The forecast reflects a market moving from a niche post-surgical device category toward a broader platform for endoscopic obesity and complication management. - Strong growth in obesity care and minimally invasive surgery suggests hospitals and outpatient centers are likely to keep expanding use of these devices. - Regional growth patterns point to a mature North American market and a faster-expanding opportunity in Asia-Pacific.

What's next: - Wider adoption of biodegradable, biocompatible and fully covered stents is likely to shape product development. - More robotic-assisted and AI-supported gastrointestinal procedures could lift demand further. - Growth in ambulatory surgical centers may shift more treatment volume away from inpatient settings. - The market is expected to stay on a double-digit growth path through 2030.

The bottom line: - Gastric bypass stent systems are moving into a faster-growth phase as obesity care, bariatric surgery follow-up and minimally invasive gastrointestinal treatment expand worldwide.